Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

White Papers and Resources | March 29, 2018 | Inizio

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...

Lucid Group are on the Lookout for World-Shaking Talent

Press Releases | March 28, 2018 | Lucid Group Communications Limited

Lucid Group kick-started the week with its second exchange day in 2018, held in their Macclesfield office. With continued growth from new and existing clients, the need to find and...

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

Press Releases | March 27, 2018 | Wilmington Healthcare

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

New insights into making behavioural change work

Press Releases | March 26, 2018 | Porterhouse Medical Group

The focus of pharmacological interventions has experienced a shift over recent years, with a greater emphasis placed on addressing lifestyle conditions than on fighting infectious diseases. Lifestyle conditions, or noncommunicable...

Fulfilling Dreams, Talent and Ambition – The Lucid Futures Academy

Press Releases | March 15, 2018 | Lucid Group Communications Limited

The inaugural class of 2018 graduate from Lucid’s Futures Academy

Wilmington Healthcare survey finds many doctors fear the NHS will fall victim to another ransomware attack

Press Releases | March 15, 2018 | Wilmington Healthcare

Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider...

Getting in the LUCID SPIRIT!

Press Releases | March 14, 2018 | Lucid Group Communications Limited

Lucid Group launches charity partnership with Wycombe Homeless Connection

Innovative NHS suppliers scoop HSJ Partnership Awards

Press Releases | March 13, 2018 | Wilmington Healthcare

Winners include pharma, medtech, healthcare consultants and IT specialists. Innovative pharma and medtech companies have been honoured in an awards scheme run by Health Service Journal (HSJ), the news and...

Rapid career progression at Porterhouse Medical

Press Releases | March 12, 2018 | Porterhouse Medical Group

We are delighted to announce another promotion within our scientific services team.

Value proposition development

White Papers and Resources | March 12, 2018 | Dovetail

Pharma companies need to demonstrate value to the NHS, so developing a clear statement to articulate that value to customers is a vital element of the marketing mix.